United European Gastroenterology Journal

Article	Citations
Liver injury in COVID‐19: The current evidence	174
European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations	115
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations	113
European guidelines on chronic mesenteric ischaemia – joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal a	93
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis	84
Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines	67
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group	62
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia	57
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutri	57
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	57
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‐analysis	48
Pancreatic cancer‐derived organoids – a disease modeling tool to predict drug response	45
European guideline on indications, performance and clinical impact of 13C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC	43
Non‐alcoholic fatty liver disease increases the risk of incident chronic kidney disease	40
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden	39
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice	39
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility	38
A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease	36
Pancreatic tuberculosis: A systematic review of symptoms, diagnosis and treatment	34
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study	34
Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease ce	34
The daily impact of COVID‐19 in gastroenterology	33
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation	32
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases	31
New concepts in the treatment of hepatocellular carcinoma	30

Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study	30
Gastric cancer in autoimmune gastritis: A case‐control study from the German centers of the staR project on gastric cancer research	29
Novel reliability criteria for controlled attenuation parameter assessments for non‐invasive evaluation of hepatic steatosis	29
Implications of the changing epidemiology of inflammatory bowel disease in a changing world	29
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration	29
Gut fermentation syndrome: A systematic review of case reports	28
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease	27
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better	26
The gastrointestinal tract in hunger and satiety signalling	25
The diagnostic work‐up and outcomes of ‘presumed’ idiopathic acute pancreatitis: A post‐hoc analysis of a multicentre observational cohort	25
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency	24
Environmental risk factors for inflammatory bowel disease	24
Time trends in incidence and prevalence of chronic pancreatitis: A 25‐year population‐based nationwide study	24
SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease	24
Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study	23
The microbiome in pancreatic diseases: Recent advances and future perspectives	23
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study	23
Discriminant and convergent validity of the GSRS‐IBS symptom severity measure for irritable bowel syndrome: A population study	22
Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials	22
Current status and limitations of artificial intelligence in colonoscopy	22
Colon capsule endoscopy versus CT colonography after incomplete colonoscopy. Application of artificial intelligence algorithms to identify complete colonic investigations	22
The global prevalence of Barrett’s esophagus: A systematic review of the published literature	22
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education ‐ a population‐based cross‐sectional study of incidence, diagnostic process and complications of eosinophilic oesophagi	22
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure	22
Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease	21
Natural history, diagnosis and treatment approach to fibrostenosing Crohn’s disease	21
Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience	21
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies	21
Patterns of liver injury in COVID‐19 – a German case series	20
Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study	20
Clinical management of patients with drug‐induced liver injury (DILI)	20
Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases	20
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register	19
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis	19
Endoscopic ultrasound‐based multimodal evaluation of the pancreas in patients with suspected early chronic pancreatitis	19
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries	19
Diagnosis and treatment of primary biliary cholangitis	19
Genomic and molecular alterations in human inflammatory bowel disease‐associated colorectal cancer	19
Clinical management of the most common extra‐intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes	18
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry	18
Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on	18
The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study	17
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline	17
Long‐term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort	17
Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland	17
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn’s disease	17
First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening	17
Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis	17
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018	17
Review of the diagnosis and management of intraductal papillary mucinous neoplasms	16

Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European Region—White Book 2: Executive summa	16
COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology	16
Management of pregnancy in women with cirrhosis	16
Ultrasonography in inflammatory bowel disease – So far we are?	15
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis	15
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population	15
Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis	15
Rising incidence of acute pancreatitis in Sweden: National estimates and trends between 1990 and 2013	15
Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer	15
Towards evidence‐based and personalised care of acute pancreatitis	15
Gastrointestinal bleeding and endoscopic findings in critically and non‐critically ill patients with corona virus disease 2019 (COVID‐19): Results from Lean European Open Survey on SARS‐CoV‐2 (LEOSS)	15
A new artificial intelligence system successfully detects and localises early neoplasia in Barrett's esophagus by using convolutional neural networks	15
Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis	15
Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review	14
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020	14
The development of a cryptoglandular Anal Fistula Core Outcome Set (AFCOS): an international Delphi study protocol	14
Suboptimal care for chronic pancreatitis patients revealed by moderate to low adherence to the United European Gastroenterology evidence‐based guidelines (HaPanEU): A Netherlands nationwide analysis	14
Gastroesophageal reflux after per‐oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case‐control study	14
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease	14
The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth	14
Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study	13
Lack of long‐term follow‐up after paediatric‐adult transition in coeliac disease is not associated with complications, ongoing symptoms or dietary adherence	13
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study	13
Cold versus hot polypectomy/endoscopic mucosal resection–A review of current evidence	13
Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance	13
Tumour‐stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case‐cohort study	13
Serum levels of ferritin and transferrin serve as prognostic factors for mortality and survival in patients with end‐stage liver disease: A propensity score‐matched cohort study	13
Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affected	13
Wound healing of metastatic perineal Crohn’s disease using hyperbaric oxygen therapy: A case series	13
Clinical management of type C hepatic encephalopathy	13
Functional dyspepsia is associated with lower exercise levels: A population‐based study	13
Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022	13
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease	13
Small bowel polyp resection using device‐assisted enteroscopy in Peutz‐Jeghers Syndrome: Results of a specialised tertiary care centre	13
Prevalence of coexisting autoimmune thyroidal diseases in coeliac disease is decreasing	13
Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?	13
Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT‐TOPIC trial after 1‐year follow‐up	13
Treat‐to‐target and sequencing therapies in Crohn's disease	13
Endoscopy works during the pandemic of coronavirus COVID‐19: recommendations by the Chinese Society of Digestive Endoscopy	13
UEG Week 2021 Poster Presentations	12
Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis	12
Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites	12
Proximal retroflexion versus second forward view of the right colon during screening colonoscopy: A multicentre randomized controlled trial	12
Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis	12
Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population	12
Cold snare polypectomy for large sessile serrated lesions is safe but follow‐up is needed: a single‐centre retrospective study	12
Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study	12
Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study	12
How to raise the interest for neurogastroenterology among young gastroenterologists?	12
Occurrence and characteristics of faecal immunochemical screen‐detected cancers vs non–screen‐detected cancers: Results from a Flemish colorectal cancer screening programme	11
Histologic parameter score does not predict short‐term survival in severe alcoholic hepatitis	11
Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease	11
Real‐time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome—A randomized controlled pilot trial (CADLY)	11
Endoscopic band ligation compared to thermal therapy for gastric antral vascular ectasia: A systematic review and meta‐analysis	11
Is tofacitinib a game‐changing drug for ulcerative colitis?	11
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision‐making programme using decision tables	11
Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study	11
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization	11
Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease	11
Tips from the battlefront: Psychological support of patients with a chronic illness during the COVID‐19 lockdown in four steps	11
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate	11
High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong	10
Young GI Societies in Europe: 2019 update	10
Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study	10
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study	10
Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines	10
High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort	10
Probe‐based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist‐blinded study	10
A starch‐ and sucrose‐reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence varian	10
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments	10
Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review	10
Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy	10
Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature	10
Standard versus Endocuff versus cap‐assisted colonoscopy for adenoma detection: A randomised controlled clinical trial	10
Young GI angle #Twitter2Paper: Taking an idea from Twitter to paper	9
Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9‐year cohort study	9
Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education	9
UEG Week 2020 Oral Presentations	9
Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression	9
German guideline diverticular disease/diverticulitis	9

Endoscopic treatment with transmural drainage and necrosectomy for walled‐off necrosis provides favourable long‐term outcomes on pancreatic function	9
Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1	9
Development and evaluation of a deep learning model to improve the usability of polyp detection systems during interventions	9
Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey	9
Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls	9
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme	9
Immunoglobulin G subtypes‐1 and 2 differentiate immunoglobulin G4‐associated sclerosing cholangitis from primary sclerosing cholangitis	9
Albumin: Indications in chronic liver disease	9
Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study	9
Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double‐blind, placebo‐controlled trial	9
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry	9
Oral health and salivary function in ulcerative colitis patients	9
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication thera	9
Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry	8
Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?	8
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	8
Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease	8
Crohn's disease related strictures in cross‐sectional imaging: More than meets the eye?	8
Diagnostic accuracy of pan‐enteric capsule endoscopy and magnetic resonance enterocolonography in suspected Crohn's disease	8
Join the myUEG community and become an official myUEG Associate for free	8
Glucose variability during the early course of acute pancreatitis predicts two‐year probability of new‐onset diabetes: A prospective longitudinal cohort study	8
The COlorectal NEoplasia Endoscopic Classification to Choose the Treatment classification for identification of large laterally spreading lesions lacking submucosal carcinomas: A prospective study of	8
Endoscopic retrograde cholangiopancreatography‐related adverse events in Korea: A nationwide assessment	8
Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors	8
UEG framework for the development of high‐quality clinical guidelines	8
Landscape of new drugs and targets in inflammatory bowel disease	8
Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review	8
AGREE‐S: AGREE II extension for surgical interventions – United European Gastroenterology and European Association for Endoscopic Surgery methodological guide	8
New endoscopic tools in inflammatory bowel disease	8
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study	8
High prevalence of ulcerative appendicitis in patients with ulcerative colitis	8
Evolving therapeutic goals in Crohn's disease management	8
Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study	8
Burnout among gastroenterologists: How to manage and prevent it	7
Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases	7
Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review	7
Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study	7
A new path for the UEG Journal	7
Digestive cancer screening across Europe	7
Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis	7
Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease	7
Post‐induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis	7
Serum phosphate is associated with mortality among patients admitted to ICU for acute pancreatitis	7
Adverse events in endoscopic retrograde cholangiopancreaticography (ERCP): Focus on post‐ERCP‐pancreatitis	7
Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis	7
Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies	7
German guideline diverticular disease/diverticulitis	7
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance	7
Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications	7
COVID‐19 and digestive health: Implications for prevention, care and the use of COVID‐19 vaccines in vulnerable patients	7
Coeliac disease re‐screening among once seronegative at‐risk relatives: A long‐term follow‐up study	7
Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease	7
Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany	7
Impact of therapies on bowel damage in Crohn’s disease	7
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients	7
Irritable bowel syndrome: Factors of importance for disease‐specific quality of life	7
Surgery for Crohn’s disease during pregnancy: A nationwide survey	7
Pouchitis: Treatment dilemmas at different stages of the disease	7
How to identify, encourage, and support suitable candidates for leading roles in scientific societies: The UEG experience	7
Creeping fat formation and interaction with intestinal disease in Crohn's disease	6
Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis—A case‐based review	6
Young GI angle: International research fellowship as a way to foster clinical research at your department – our stories	6
Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements	6
Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study	6
New risk stratification after colorectal polypectomy reduces burden of surveillance without increasing mortality	6
Trends in inflammatory bowel disease treatment in the past two decades‐a high‐level text mining analysis of PubMed publications	6
Horizon Europe, the new programme for research & innovation: Which opportunities for GI research in the years to come?	6
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis	6
Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease	6
Digestive diseases: Big burden, low funding? Results of the new United European Gastroenterology White Book on digestive diseases	6
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial	6
Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography	6
Gastric cancer detection by non‐blood‐based liquid biopsies: A systematic review looking into the last decade of research	6
Capability of processed EEG parameters to monitor conscious sedation in endoscopy is similar to general anaesthesia	6
Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from Italy	5
A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey	5
UEG Week 2022 Poster Presentations	5
Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence	5
Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma	5
Comparison of various strategies to define the optimal target population for liver fibrosis screening: A population‐based cohort study	5
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients	5
Towards a robust and compact deep learning system for primary detection of early Barrett’s neoplasia: Initial image‐based results of training on a multi‐center retrospectively collected data set	5
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis	5
The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis	5
Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease	5
Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes	5
A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome	5
Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study	5
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort	5
Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies	5
Letter of Thanks for UEG Week 2022 Reviewers	5
Metabolic endoscopy: Today’s science—tomorrow’s treatment	5
Burn‐out and employability rates are impacted by the level of job autonomy and workload among Dutch gastroenterologists	5
UegWeek 2020 Poster Presentations	4
Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia–A narrative review	4